Ben Hsu is a seasoned professional in clinical development, currently serving as Vice President of Clinical Development for Autoimmune at Adicet Bio, Inc. since March 2024. Previously, Ben held the position of VP, Clinical Development at Sangamo Therapeutics from November 2020 to March 2024, and served as VP, General Medicine at UNITY Biotechnology from October 2018 to November 2020. Ben's extensive experience in clinical research includes a role as Senior Director at Johnson & Johnson/Janssen R&D, overseeing clinical trials for various autoimmune conditions, and earlier positions focused on rheumatology at the University of Pennsylvania and translational medicine at Glaxo. Ben obtained a Rheumatology Fellowship at the University of Pennsylvania, an MD and PhD in Immunology from Washington University in St. Louis, and an A.B. in Biochemistry, magna cum laude, from Harvard University.
This person is not in any teams
This person is not in any offices